本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

TELA Bio, Inc.

1.89
-0.0600-3.08%
盤後1.890.00000.00%16:18 EDT
成交量:11.73萬
成交額:22.18萬
市值:7,475.85萬
市盈率:-1.46
高:1.99
開:1.99
低:1.82
收:1.95
資料載入中...
2024/07/02

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/17

SEC問詢函

Form CORRESP - Correspondence
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/10/21

重要事件披露

Form 8-K - Current report
2023/10/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals